What People Are Saying
The sRNAlytics platform illuminates 'dark matter' in biological data, allowing the development of precise diagnostics and therapeutics
- Dr. Jun Axup Science Director, IndieBio
sRNAlytics’ platform has application across many areas of interest to AstraZeneca. We’re excited to watch their company mature in the [AstraZeneca] incubator and work with them.
- Head of Neurology, AstraZeneca
sRNAlytics is uncovering biomarkers that make it feasible to identify people who will develop neurological diseases, but do not yet show any symptoms
- Dr. Richard H. Myers Professor, Boston University